Home » Products » Anti Cancer Medicine » Crizocent Tablet

Crizocent Tablet

Crizocent Tablet
Crizocent Tablet
Send Inquiry
Product Code : asp
Brand Name : Crizocent
Price And Quantity
  • Minimum Order Quantity
  • 10 Pack
  • Price
  • 1 USD ($)/Unit
Product Specifications
  • Drug Type
  • Other Types
  • Ingredients
  • Crizotinib
  • Physical Form
  • Capsules
  • Function
  • Anti-Cancer
  • Dosage
  • 250 mg in each Capsules
  • Dosage Guidelines
  • 250 mg in each Capsules
  • Quantity
  • 10 Unit
Product Description

Specification

Brand

Crizocent

Packaging Type

Bottle

Usage/Application

Cancer

Anti Cancer Medicine Type

Non-small cell Lung Cancer

Composition

Crizotinib 250mg

Drug Name

Crizotinib 250mg

Packaging Size

60 Caps

Dose Strength

250mg

Category

Lung Cancer

Drug

Crizotinib 250mg

Generic Name

Crizotinib 250mg

AsparĀ® Pharmaceuticals is a leading manufacturer and exporter of Crizocent Capsule (Crizotinib 250mg) in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

 

Indication: Crizocent Capsule (Crizotinib 250mg) Crizocent Capsule is used to treatment of Non-small cell Lung Cancer. 

 

Uses:- Crizocent Capsule (Crizotinib 250mg) Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Crizocent Capsule may be taken with or without food, but it is better to take it at a fixed time.

 

How it works:- Crizocent Capsule (Crizotinib 250mg) Crizocent Capsule is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

 

Available other Brand : Crizalk.

Trade Information
  • FOB Port
  • mumbai
  • Supply Ability
  • 1000 Pack Per Day
  • Delivery Time
  • 10 Days
  • Sample Policy
  • Contact us for information regarding our sample policy
  • Packaging Details
  • 60 Capsules

ASPAR PHARMACEUTICALS
X


ASPAR PHARMACEUTICALS All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.